Amicus Therapeutics to Present at the Cowen & Company 40th Annual Health Care Conference

CRANBURY, N.J., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics, Inc. (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the Cowen & Company 40th Annual Health Care Conference in Boston, MA on Tuesday, March 3, 2020 at 8:40 a.m. ET.

A live audio webcast of the presentation can also be accessed via the Investors section of the Amicus Therapeutics corporate website at, and will be archived for 90 days.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at, and follow on Twitter and LinkedIn.


Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
(609) 662-3809

Amicus Therapeutics
Christopher Byrne
Executive Director, Corporate Communications
(609) 662-2798


Primary Logo

Back to news